Immediate Impact
59 standout
Citing Papers
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
The cGAS‒STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications
2025 Standout
Works of Marcus J. Daniels being referenced
Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
2019
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Marcus J. Daniels | 260 | 95 | 50 | 87 | 17 | 382 | |
| Ashraf Zaghloul | 179 | 86 | 38 | 94 | 19 | 397 | |
| Eric Ballon‐Landa | 58 | 78 | 76 | 52 | 18 | 340 | |
| C.L. Alons | 238 | 70 | 74 | 79 | 14 | 434 | |
| N W Derias | 122 | 110 | 66 | 75 | 22 | 403 | |
| Katrina McGinty | 135 | 112 | 69 | 53 | 20 | 345 | |
| Glen Yang | 128 | 21 | 69 | 142 | 17 | 429 | |
| Michael Jewett | 214 | 93 | 184 | 117 | 21 | 389 | |
| Arighno Das | 147 | 74 | 98 | 89 | 25 | 350 | |
| E. Becht | 221 | 53 | 88 | 150 | 17 | 439 | |
| Andrew Rothman | 268 | 91 | 113 | 24 | 11 | 389 |
All Works
Login with ORCID to disown or claim papers
Loading papers...